|Rapid Review Complete
|For the treatment of squamous cell carcinoma of the head and neck (SCCHN) in adults progressing on or after platinum-based therapy.
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full Pharmacoeconomic Evaluation Recommended at the Submitted Price.
The HSE has approved reimbursement following confidential price negotiations May 2018.